Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "CAMBRIA 1 Study of Extended Adjuvant Therapy With Camizestrant vs. Standard ET in Patients With ER+/HER2- Early BC and an Intermediate/High Risk of Recurrence"
By
Insights from 2023 SABCS
FEATURING
Erika Hamilton
By
Insights from 2023 SABCS
FEATURING
Erika Hamilton
332 views
December 19, 2023
Login to view comments.
Click here to Login
Videos